Subsidy Information and Financing Scheme SDLPrednisolone Syrup 5 mg/5 mL, 10 mg/5 mL SDLPrednisolone Tablet 1 mg, 5 mg, 20 mg MSHLPrednisolone Tablet 1 mg, 5 mg, 20 mg For cancer treatment. MSHLPrednisolone Syrup 5 mg/5 mL, 10 mg/5 mL For cancer treatment.
Drug Guidance for Subsidy 01/04/2023 Review of cancer supportive care medicines >RThe Ministry of Health’s Drug Advisory Committee has reviewed the available clinical evidenc... See all × 01/04/2023 Review of cancer supportive care medicines >RThe Ministry of Health’s Drug Advisory Committee has reviewed the available clinical evidence for cancer supportive care medicines routinely used in public healthcare institutions to update the MOH List of Subsidised Drugs in line with local clinical practice. The following medicines have been recommended for inclusion on the MOH Standard Drug List (SDL) or Medication Assistance Fund (MAF) in line with their registered indications or specific clinical criteria for cancer supportive care, in view of clinical need and acceptable clinical and cost-effectiveness: Aprepitant 125 mg and 80 mg tri-pack capsules; Cetirizine 10 mg tablet; Denosumab 60 mg/mL prefilled syringe; Denosumab 120 mg/1.7 mL solution for injection; Epoetin alfa 10,000 international units/mL and 40,000 international units/mL prefilled syringes; Epoetin beta 10,000 international units/0.6 mL and 30,000 international units/0.6 mL prefilled syringes; Folic acid 400 mcg tablet; Granisetron 1 mg tablet; Granisetron 1 mg/mL and 3 mg/3 mL solution for injection; Ketamine 500 mg/10 mL solution for injection; Montelukast 10 mg tablet; Oxycodone 5 mg and 10 mg capsules; Posaconazole 100 mg delayed-release tablet; Pegfilgrastim (Neulastim) 6 mg/0.6 mL prefilled syringe; Pegfilgrastim biosimilar (Fulphila) 6 mg/0.6 mL prefilled syringe; Pregabalin 25 mg, 50 mg, 75 mg, 100 mg, 150 mg and 300 mg capsules; Ranitidine 150 mg tablet; and Voriconazole 50 mg and 200 mg tablets. NRMedicines that have not been recommended for subsidy due to unacceptable cost-effectiveness are listed in the Annex. The clinical indications, subsidy class and subsidy implementation dates (if applicable) for all medicines included in the review are provided in the Annex.
Post Marketing Information DHCPL 15/12/2017 Xofigo® (radium-223 dichloride)– Important safety information update regarding increased incidence of deaths and fractures in a randomised clinical trial used in combination with abiraterone acetate and prednisolone/prednisone
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Syrup 10 mg/5 mL Alexandra Hospital Changi General Hospital Khoo Teck Puat Hospital National Skin Centre Ng Teng Fong General Hospital National University Hospital Sengkang General Hospital Singapore General Hospital SingHealth Polyclinics Woodlands Health Campus Tablet 1 mg Alexandra Hospital Changi General Hospital Institute of Mental Health KK Women's and Children's Hospital Khoo Teck Puat Hospital National Cancer Centre National Heart Centre National Healthcare Group Polyclinics National Skin Centre Ng Teng Fong General Hospital National University Hospital National University Polyclinics Sengkang General Hospital Singapore General Hospital SingHealth Polyclinics Singapore National Eye Centre Tan Tock Seng Hospital Woodlands Health Campus Tablet 5 mg Alexandra Hospital Changi General Hospital Institute of Mental Health KK Women's and Children's Hospital Khoo Teck Puat Hospital National Cancer Centre National Heart Centre National Healthcare Group Polyclinics National Skin Centre Ng Teng Fong General Hospital National University Hospital National University Polyclinics Sengkang General Hospital Singapore General Hospital SingHealth Polyclinics Singapore National Eye Centre Tan Tock Seng Hospital Woodlands Health Campus Tablet 20 mg Changi General Hospital KK Women's and Children's Hospital Khoo Teck Puat Hospital National Cancer Centre Ng Teng Fong General Hospital National University Hospital Sengkang General Hospital Singapore General Hospital Singapore National Eye Centre Tan Tock Seng Hospital Woodlands Health Campus Ophthalmic Solution 10.5 mg/mL Alexandra Hospital Changi General Hospital KK Women's and Children's Hospital Khoo Teck Puat Hospital Ng Teng Fong General Hospital National University Hospital Sengkang General Hospital Singapore General Hospital Singapore National Eye Centre Tan Tock Seng Hospital Woodlands Health Campus Syrup 5 mg/5 mL KK Women's and Children's Hospital
OPHTHALMIC Select a brand starting with the letter: P PRED FORTE OPHTHALMIC SUSPENSION 1% [SIN04661P]
ORAL Select a brand starting with the letter: D P W X Y DELTASOLONE TABLET 5 MG [SIN04187P] DHASOLONE TABLET 5 MG [SIN04207P] PREDNISOLONE SYRUP 5 MG/5 ML [SIN09126P] PREDNISOLONE TABLET 1 MG [SIN05149P] PREDNISOLONE TABLET 20 MG [SIN07628P] See all PREDNISOLONE TABLET 5 MG [SIN04237P] PRELONE SYRUP 3 MG/5 ML [SIN04845P] WALESOLONE SYRUP 10 MG/5 ML [SIN07848P] XEPASONE TABLET 5 MG [SIN04190P] YSP PREDNISOLONE TABLET 5 MG [SIN07771P]